Experiment 505091

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

GOMISIN A

Details

PropertyValue
Pharmacology
CARCINOGENESIS INHIBITION
Administration routeINTRAGASTRIC
OrganismEmpty organism
CitationOHTAKI,Y: NOMURA,M: HIDA,T: MIYAMOTO,K: KANITANI,M: AIZAWA,T: ABURADA,M:. (1994). INHIBITION BY GOMISIN A, A LIGNAN COMPOUND, OF HEPATOCARCINOGENESIS BY 3'-METHYL-4-DIMETHYLAMINOAZOBENZENE IN RATS.. 17(6)
Amount utilized
Compound isolated
DiseaseVS.3'MEDAB-INDUCED CARCINOGENESIS THE DRUG ENHANCES EXCRETION OF CARCINOGEN AND REVERSES THE NORMAL CYTOKINESIS.
Dose amount30.0 MG
Number1
Qualitative resultACTIVE
AnimalRAT
Per unitKG
Dose expressionDOSE
GenderMALE